Back to YC Companies
AOA Dx
Summer 2021
Active
Blood Test for Early Detection of Ovarian Cancer
25 people View on YC
AOA Dx at a glance
- Y Combinator batch
- Summer 2021
- Status
- Active
- Industry
- Healthcare
- Team size
- 25 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About AOA Dx
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Tags:
Healthcare
Diagnostics
Women's Health